SecurityBSX / Boston Scientific Corp.
Institution1832 Asset Management L.P.
Shares0
Value $ 0
Related 101137AJ6 / Boston Scientific Corp 4.50% Senior Notes 01/15/15
101137AD9 / Boston Scientific Corp 5.125% Notes 01/12/17
101137AB3 / Boston Scientific Corp 5.450% Notes 06/15/14
101137AK3 / Boston Scientific Corp 6.0% Senior Notes 01/15/20
101137AG2 / Boston Scientific Corp 6.4% Senior Notes 6/15/16
101137AL1 / Boston Scientific Corp 7.375% Senior Notes 01/15/40

1832 Asset Management L.P. closes position in BSX / Boston Scientific Corp.

February 14, 2018 - 1832 Asset Management L.P. has filed a 13F-HR form disclosing ownership of 0 shares of Boston Scientific Corp. (NYSE:BSX) with total holdings valued at $0 USD as of December 31, 2017. 1832 Asset Management L.P. had filed a previous 13F-HR on November 14, 2017 disclosing 8,008 shares of Boston Scientific Corp. at a value of $227,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.

Other investors with closed positions include Ing Groep Nv, Maverick Capital Ltd, Dynamic Technology Lab Private Ltd, Icon Advisers Inc/co, and Bridgewater Associates, LP.

Boston Scientific Corp. has declared a standard industrial code (sic) of 3841 which is the "Surgical and Medical Instruments and Apparatus" industry. 1832 Asset Management L.P.'s top industries are "Construction Special Trade Contractors" (sic 17), "Primary Metal Industries" (sic 33), and "Home Furniture, Furnishings, And Equipment Stores" (sic 57).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-12-31 13F-HR BOSTON SCIENTIFIC COM 101137107 0 -100.00 0 -100.00
2017-09-30 13F-HR BOSTON SCIENTIFIC COM 101137107 8,008 227
2016-12-31 13F-HR BOSTON SCIENTIFIC COM 101137107 0 -100.00 0 -100.00
2016-09-30 13F-HR BOSTON SCIENTIFIC COM 101137107 640 15

Related SEC Filings

BSX / Boston Scientific Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Boston Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 101137107 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of th

BSX / Boston Scientific Corp. / Capital World Investors - SC 13G/A (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Boston Scientific Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 101137107 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of th

BSX / Boston Scientific Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 5 BOSTON SCIENTIFIC CORP COMMON STOCK Cusip #101137107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #101137107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 9,999,715 Item 6: 0 Item 7: 157,515,743 Item 8: 0 Item 9: 157,515,743 Item 11: 11.

BSX / Boston Scientific Corp. / FMR LLC / Fidelity - 3G/A (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 5 BOSTON SCIENTIFIC CORP COMMON STOCK Cusip #101137107 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #101137107 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 9,999,715 Item 6: 0 Item 7: 157,515,743 Item 8: 0 Item 9: 157,515,743 Item 11: 11.

BSX / Boston Scientific Corp. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
bostonscientificcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 4 )*       Name of issuer:  Boston Scientific Corp     Title of Class of Securities:  Common Stock     CUSIP Number:  101137107     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:  

Related News Stories

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

20h 247wallst
Stocks were indicated higher on Tuesday after a follow-on rally failed to hold by Monday’s close. While the market’s all-time highs are still within striking distance, investors have seen lower upside from buying immediately after the big market pullbacks in 2018 than in prior years. And the financial media keeps referring to a “peak cycle” with strong earnings. Now investors have to be considering how they want to position their investments for the rest of the year and into 2019. (67-0)

Here's Why You Should Invest in Boston Scientific Stock Now

2018-10-09 zacks
Boston Scientific Corporation (BSX - Free Report) has been gaining investor confidence on consistently encouraging results. Over the past six months, the company’s share price has outperformed its industry. The stock has gained 27.1% compared with the industry’s 19% rally. Also, the company has outperformed the S&P 500’s 8.7% rise. (4-0)

How Indian stent maker SMT is taking the battle to MNC shores

2018-10-09 moneycontrol
Sahajanand Medical Technologies, or SMT, the Surat-based maker of cardiac stents isn’t content with what it has achieved in India. The management now wants to take the battle to foreign shores. (10-0)

Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again

2018-10-05 zacks
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Boston Scientific (BSX - Free Report) , which belongs to the Zacks Medical - Products industry, could be a great candidate to consider. (7-0)

Can You Still Profit From Boston Scientific’s Tremendous Run?

2018-10-03 investorplace
Over the last six months, Boston Scientific (NYSE:BSX) has experienced an incredible rally. BSX stock has moved higher in 24 of the past 28 weeks, a streak that started back in March. (3-0)



CUSIP: 101137107